AI assistant
Sending…
RESMED INC — Director's Dealing 2015
May 19, 2015
30071_dirs_2015-05-19_8221e978-457e-4430-b3c7-210d3e159fea.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-05-15
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-15 | ResMed Common Stock | M | 5975 | $15.52 | Acquired | 128414.946 | Direct |
| 2015-05-15 | ResMed Common Stock | S | 5975 | $56.62 | Disposed | 122439.946 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-15 | ResMed Common Stock Options | $15.52 | M | 5975 | Disposed | 2015-11-20 | ResMed Commmon Stock (5975) | Direct |
Footnotes
F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
F2: Represents date options first became exercisable. Options vest 1/4 annually.
F3: Includes 84.006 shares of ResMed stock purchased on April 30, 2015, through the Employee Stock Purchase Plan.
More from RESMED INC
Regulatory Filings
2026
Jul 7
Call Transcript
2026
Jun 2
Regulatory Filings
2026
May 26
Call Transcript
2026
Apr 30
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6